(Q35003701)

5 August 2017

1 reference

title

Novel human polysaccharide adjuvants with dual Th1 and Th2 potentiating activity (English)

1 reference

5 August 2017

1 reference

Nikolai Petrovsky

1

0 references

language of work or name

English

0 references

publication date

1 April 2006

1 reference

5 August 2017

1 reference

5 August 2017

volume

24 Suppl 2

1 reference

5 August 2017

page(s)

S2-26-9

1 reference

The development and use of vaccine adjuvants

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

8 July 2018

Adjuvants in perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Adjuvants--a balance between toxicity and adjuvanticity

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Adjuvants: current status, clinical perspectives and future prospects

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Vaccine adjuvants based on gamma inulin.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Structural and immunological characterization of the vaccine adjuvant QS-21.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Uveitis induction in the rabbit by muramyl dipeptides

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

The adjuvanticity of Algammulin, a new vaccine adjuvant.

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

The immune system evolved to discriminate infectious nonself from noninfectious self

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Immunological adjuvants and their mode of action

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

An update on vaccine adjuvants in clinical trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Advantages of Aluminium Hydroxide Adsorbed Combined Diphtheria, Tetanus, and Pertussis Vaccines for the Immunization of Infants

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3101117

Immunological adjuvants: Desirable properties and side-effects

26 October 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.107

Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.107

New meanings for an old word: adjuvanticity, cytokines and T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.107

Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.107

Algammulin, a new vaccine adjuvant comprising gamma inulin particles containing alum: preparation and in vitro properties

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.01.107

The mode of action of immunologic adjuvants

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16823913

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16823913

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.01.107

1 reference

5 August 2017

1 reference

5 August 2017

1 reference